Search
Categories
Hot topics close

Lower price for MS drug paves the way for positive recommendation from NICE

Lower price for MS drug paves the way for positive recommendation from NICE
In its final draft guidance published today (9 May 2019), NICE has reversed its previous draft decision not to recommend ocrelizumab (Ocrevus, Roche) for treating primary progressive multiple sclerosis (PPMS) in adults. This follows an agreement between".
Similar news
News Archive
  • Tottenham vs Morecambe
    Tottenham vs Morecambe
    Tottenham vs Morecambe: Player ratings and analysis as Kane and Moura spare Spurs’ blushes in the FA Cup
    9 Jan 2022
    5
  • Digital detox
    Digital detox
    Digital Detox in 2024. Digital detox is reducing or… | by Avinash Bangera | Jan, 2024
    26 Jan 2024
    4
  • Data visualization
    Data visualization
    Lifesciences Data Mining and Visualization Market Size & Revenue Analysis | Tableau Software, SAP SE, IBM
    10 Mar 2022
    3
  • NHS booster jab
    NHS booster jab
    Seven announcements from Boris Johnson's Covid-19 press conference, with 'booster' jab for every adult
    30 Nov 2021
    3
  • Meat Loaf
    Meat Loaf
    Meat Loaf: What exactly is it that the singer would not do for love?
    21 Jan 2022
    5
  • Jinkx Monsoon
    Jinkx Monsoon
    Jinkx Monsoon Will Fight 'Tooth and Nail' to Keep Queer Talent in ...
    11 May 2024
    2
This week's most popular news